Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study.
Jiesuck ParkEue-Keun ChoiKyung-Do HanYou-Jung ChoiEuijae LeeWonseok ChoeSo-Ryoung LeeMyung-Jin ChaWoo-Hyun LimJeehoon KangKyung Woo ParkSeil OhGregory Y H LipPublished in: PloS one (2019)
From 2006 to 2015, the number of patients with AF undergoing PCI and the prescription rate of triple therapy increased gradually with a recent increment of NOAC-based antithrombotic therapy from 2013. Previous myocardial infarction, peripheral artery disease, and PCI were associated with underuse of triple therapy.
Keyphrases
- atrial fibrillation
- percutaneous coronary intervention
- oral anticoagulants
- acute myocardial infarction
- acute coronary syndrome
- st segment elevation myocardial infarction
- coronary artery disease
- antiplatelet therapy
- heart failure
- st elevation myocardial infarction
- peripheral artery disease
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- coronary artery bypass grafting
- risk factors
- left ventricular
- cross sectional
- mesenchymal stem cells
- combination therapy
- cell therapy